Baxter
Baxter is an Ilinois-based healthcare company that designs and distributes nutritional, renal and surgical care products for medical centers.
Business Model:
Revenue: $13.5B
Employees: 10,001-999,999
Industries / Tags:
Detailed Baxter Information
Geographic Data
Address: 1 Baxter Parkway
City: Deerfield
State: IL
Zip: 60015
Country: US
Financial Info
Stage:
grant
Raised Last:
$2M
Raised Total:$2B
Social
Metrics
174,771Website Global Rank
429,775Website Monthly Traffic
Twitter Followers
Description
Baxter is an Ilinois-based healthcare company that designs and distributes nutritional, renal and surgical care products for medical centers.
Contact Phone:
+18442945418
Contact Email:
Baxter went public on 1/13/1978 on the NYSE
Listed Exchange:
NYSE
IPO Date:
1/13/1978
Ticker Symbol:
BAX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2013 | Zytoprotec | Series A | 2.7M |
| 10/2012 | Gliknik | Series B | 9.9M |
| 1/2022 | Medically Home | Venture Round | 0 |
| 12/2012 | Naurex | Series B | 0 |
| 5/2014 | Naurex | Series C | 0 |
| 3/2022 | NovaXS Biotech | Seed Round | 0 |
| 11/2021 | Walela | Seed Round | 0 |
| 1/2014 | Xenetic Biosciences | Post-IPO Equity | 10M |
| 10/2013 | Opsona | Series C | 0 |
| 4/2013 | Opsona | Series C | 0 |
| 5/2020 | Ayogo Health | Series B | 0 |
| 6/2013 | Ocular Therapeutix | Series D | 23.8M |
| 3/2022 | NovaXS Biotech | Seed Round | 0 |
| 1/2022 | Medically Home | Venture Round | 0 |
| 11/2021 | Walela | Seed Round | 0 |
| 5/2020 | Ayogo Health | Series B | 0 |
| 5/2014 | Naurex | Series C | 0 |
| 1/2014 | Xenetic Biosciences | Post-IPO Equity | 0 |
| 10/2013 | Opsona | Series C | 0 |
| 6/2013 | Ocular Therapeutix | Series D | 0 |
| 4/2013 | Opsona | Series C | 0 |
| 1/2013 | Zytoprotec | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2021 | Post-IPO Debt | $2.5B |
JPMorgan Chase Bank |
5/2019 | Post-IPO Debt | $1.7B | 4/2021 | Grant | 1 | $1.8M |
German Federal Ministry of Education and Research (BMBF) German Federal Ministry of Education and Research (BMBF) German Federal Ministry of Education and Research (BMBF) German Federal Ministry of Education and Research (BMBF) |
4/2021 | Grant | $1.8M |
German Federal Ministry of Education and Research |
1/1978 | IPO | - | 1/1978 | IPO | - |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 9/2021 | Hill-Rom | |
| 12/2019 | Seprafilm | |
| 9/2019 | Cheetah Medical | |
| 12/2016 | Claris Injectables | |
| 3/2015 | SuppreMol | |
| 7/2014 | AesRx | |
| 4/2014 | Chatham Therapeutics | |
| 9/2013 | FLOWSENSE | |
| 9/2013 | Gambro | |
| 2/2012 | Synovis Life Technologies |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
